The Clorox Company $CLX Shares Sold by Savant Capital LLC

Savant Capital LLC decreased its stake in The Clorox Company (NYSE:CLX) by 65.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,330 shares of the company’s stock after selling 6,368 shares during the quarter. Savant Capital LLC’s holdings in Clorox were worth $336,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of CLX. Van ECK Associates Corp grew its position in shares of Clorox by 93.9% in the third quarter. Van ECK Associates Corp now owns 2,709,972 shares of the company’s stock valued at $334,139,000 after purchasing an additional 1,312,471 shares during the period. Invesco Ltd. lifted its stake in shares of Clorox by 23.1% in the third quarter. Invesco Ltd. now owns 3,995,590 shares of the company’s stock worth $492,656,000 after buying an additional 750,415 shares in the last quarter. Northwestern Mutual Wealth Management Co. lifted its stake in shares of Clorox by 6,907.9% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 749,703 shares of the company’s stock worth $75,593,000 after buying an additional 739,005 shares in the last quarter. Worldquant Millennium Advisors LLC purchased a new position in shares of Clorox in the second quarter worth about $71,856,000. Finally, Two Sigma Investments LP lifted its stake in shares of Clorox by 33.8% in the third quarter. Two Sigma Investments LP now owns 1,740,175 shares of the company’s stock worth $214,564,000 after buying an additional 439,797 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Stock Performance

Clorox stock opened at $94.07 on Friday. The firm has a 50 day simple moving average of $96.95 and a 200-day simple moving average of $105.31. The stock has a market cap of $11.37 billion, a price-to-earnings ratio of 15.27, a price-to-earnings-growth ratio of 0.46 and a beta of 0.56. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65. The Clorox Company has a 1-year low of $84.70 and a 1-year high of $132.03.

Clorox (NYSE:CLX) last released its quarterly earnings data on Thursday, April 30th. The company reported $1.64 EPS for the quarter, beating analysts’ consensus estimates of $1.55 by $0.09. The firm had revenue of $1.67 billion for the quarter, compared to analysts’ expectations of $1.67 billion. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The firm’s quarterly revenue was up .1% on a year-over-year basis. During the same period in the prior year, the firm posted $1.45 earnings per share. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, analysts expect that The Clorox Company will post 5.61 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on CLX shares. Evercore reissued an “underperform” rating and issued a $110.00 price target on shares of Clorox in a research note on Friday, May 1st. Zacks Research downgraded shares of Clorox from a “hold” rating to a “strong sell” rating in a research note on Tuesday, May 12th. JPMorgan Chase & Co. decreased their price target on shares of Clorox from $99.00 to $95.00 and set an “underweight” rating on the stock in a research note on Friday, May 1st. Wall Street Zen raised shares of Clorox from a “sell” rating to a “hold” rating in a research note on Saturday, February 7th. Finally, Wells Fargo & Company decreased their price target on shares of Clorox from $100.00 to $95.00 and set an “equal weight” rating on the stock in a research note on Monday, May 18th. One investment analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Reduce” and a consensus price target of $103.40.

Insider Transactions at Clorox

In other Clorox news, Director Pierre R. Breber bought 5,000 shares of the business’s stock in a transaction on Tuesday, May 5th. The stock was bought at an average price of $85.82 per share, with a total value of $429,100.00. Following the completion of the purchase, the director directly owned 18,000 shares in the company, valued at $1,544,760. The trade was a 38.46% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.63% of the stock is currently owned by company insiders.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.